OKYO Pharma
Develops urcosimod eye drops for neuropathic corneal pain and anterior-segment eye diseases.
$1.64
After-hours close−0.01 (−0.61%)
At close$1.65(+6.45%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions —Insiders 56.39%
Shares outstanding 38.37M · Float —
Float — provider float is below the insider stake.
The provider's float is smaller than the insider stake it should exclude, so it is not shown.
Institutions13F
No 13F holders on record.
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Chernett Jorey | 9.50% | 3.80M | 13G | Feb 13, 2026 ↗ |
| Sirenia Capital Management LP | 7.70% | 4.05M | 13G | May 15, 2026 ↗ |
| Woodline Partners LP | 7.00% | 3.65M | 13G | May 15, 2026 ↗ |
| Laura Natalia Monica Fonda | 5.01% | 1.93M | 13G | Oct 29, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Gabriele M. Cerrone | director, 10 percent owner: | 21.40M | 55.78% | Aug 7, 2026 |
| Gary S. Jacob | director, officer: CHIEF DEVELOPMENT OFFICER | 112.4K | 0.29% | Aug 7, 2026 |
| John P. Brancaccio | director | 35.2K | 0.09% | Aug 7, 2026 |
| Rajkumar V. Patil | officer: Chief Scientific Officer | 20.0K | 0.05% | Aug 7, 2026 |
| Flavio Mantelli | officer: CHIEF MEDICAL OFFICER | 20.0K | 0.05% | Aug 7, 2026 |
| Keeren Rameshchandra Shah | officer: CHIEF FINANCIAL OFFICER | 16.7K | 0.04% | May 22, 2026 |
| Willy Jules Simon | director | 15.4K | 0.04% | Jun 1, 2026 |
| Robert John Dempsey | director, officer: CHIEF EXECUTIVE OFFICER | 15.0K | 0.04% | Aug 7, 2026 |
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 27, 2026 | Rajkumar V. Patilofficer: Chief Scientific Officer | Purchase | 3,363 | $1.49 | 20,030 |
| Jul 21, 2026 | Flavio Mantelliofficer: CHIEF MEDICAL OFFICER | Purchase | 20,000 | $1.40 | 20,000 |
| Jul 20, 2026 | Gabriele M. Cerronedirector, 10 percent owner: | Purchase | 25,000 | $1.40 | 10,851,416 |
| Jul 21, 2026 | Gabriele M. Cerronedirector, 10 percent owner: | Purchase | 22,500 | $1.45 | 10,873,916 |
| Jul 21, 2026 | Gary S. Jacobdirector, officer: CHIEF DEVELOPMENT OFFICER | Purchase | 3,500 | $1.40 | 112,420 |
| Jul 22, 2026 | Robert John Dempseydirector, officer: CHIEF EXECUTIVE OFFICER | Purchase | 15,000 | $1.54 | 15,000 |
| Jul 21, 2026 | John P. Brancacciodirector | Purchase | 5,000 | $1.48 | 35,201 |
CongressHouse and Senate disclosures
Not reported.